Fig. 1From: Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever – a randomized controlled noninferiority trialFlowchart of the patients through the study. A total of 92 patients were eligible for the study. Two of the patients were excluded due to having additional rheumatologic diseases. After randomization, three patients in the once-daily dosage group and five patients in the twice-daily dosage group were lost to follow-up. In the twice-daily dosage group, three patients refused treatmentBack to article page